Ignite Creation Date:
2024-05-06 @ 3:55 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02408796
Status:
COMPLETED
Last Update Posted:
2020-10-19
First Post:
2015-03-27
Brief Title:
Open-Label Study of OTO-201 for Treatment of AOMT
Sponsor:
Otonomy Inc
Organization:
Otonomy Inc
Study Overview
Official Title:
A 1-Month Prospective Multicenter Open-Label Study of OTO-201 Given as a Single Supra-Tympanostomy Tube Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects
Status:
COMPLETED
Status Verified Date:
2020-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 1-month prospective multicenter open-label study in pediatric subjects with either unilateral or bilateral acute otitis media with tympanostomy tubes AOMT Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ears The study is designed to characterize safety procedural factors and clinical effect of OTO-201 administered in subjects with AOMT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None